# Superficial Parasternal Block Combined With Rectus Sheath Block for Open Cardiac Surgery

Study · id `cardio:ct-nct07890857` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07890857](<https://clinicaltrials.gov/study/NCT07890857>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07890857

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT07890857. Randomized; double masking; primary purpose treatment. Start 2026-11-01 (anticipated); primary completion 2028-11-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT07890857, source copy `cardio:ctgov-nct07890857-2026-10-22`, retrieved 2026-10-26)
- Planned start: 2026-11-01 (anticipated) (ClinicalTrials.gov record NCT07890857, source copy `cardio:ctgov-nct07890857-2026-10-22`, retrieved 2026-10-26)
- Primary completion: 2028-11-01 (anticipated) (ClinicalTrials.gov record NCT07890857, source copy `cardio:ctgov-nct07890857-2026-10-22`, retrieved 2026-10-26)
- Completion: 2028-11-30 (anticipated) (ClinicalTrials.gov record NCT07890857, source copy `cardio:ctgov-nct07890857-2026-10-22`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT07890857, source copy `cardio:ctgov-nct07890857-2026-10-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07890857-2026-10-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Superficial Parasternal Block Combined With Rectus Sheath Block for Open Cardiac Surgery
- Condition: Cardiac Valve Disease
- Condition: Coronary Heart Disease
- Intervention (Drug): Parasternal and rectus sheath block, ropivacaine 0.25 %
- Lead sponsor: Hôpital du Valais
- Lead sponsor class: OTHER
- Collaborator: University of Lausanne Hospitals
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as a collaborator: University of Lausanne Hospitals (`cardio:org-university-of-lausanne-hospitals`)

## Provenance

Content hash: 9f9b46d239f7e09763b3a88317237404e10627deabd8e3f64ab62d797ade802c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
